Eloxx Pharmaceuticals, Inc. (ELOX) — Cash Flow-to-Debt Ratio
Latest as of June 2026:
-0.28x
Eloxx Pharmaceuticals, Inc. (ELOX) has a Cash Flow-to-Debt Ratio of -0.28x as of June 2026, meaning its operating cash flow of $-4.79 Million could theoretically repay 0% of its total liabilities ($16.97 Million) in one year. See financial flexibility index of Eloxx Pharmaceuticals, Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.28x
Operating CF / Total Liabilities
Operating Cash Flow
$-4.79 Million
USD
Total Liabilities
$16.97 Million
USD
Data as of
Jun 2026
Most recent filing
Eloxx Pharmaceuticals, Inc. Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Eloxx Pharmaceuticals, Inc. across 4 annual periods. For the full cash flow conversion analysis, see Eloxx Pharmaceuticals, Inc. (ELOX) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Eloxx Pharmaceuticals, Inc. (2022–2025)
Year-by-year debt coverage analysis for Eloxx Pharmaceuticals, Inc..
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.37x | $-6.33 Million | $17.18 Million | ▼ -113.4% |
| 2024 | -0.17x | $-4.71 Million | $27.31 Million | ▲ +70.7% |
| 2023 | -0.59x | $-14.34 Million | $24.31 Million | ▲ +41.1% |
| 2022 | -1.00x | $-31.84 Million | $31.78 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.